Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vikas K Sarna

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2025
Vikas K Sarna
Gastroenterology|November 18, 2017
HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten ConsumptionVikas K Sarna, Knut E A Lundin, Lars Mørkrid, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten ChallengeJorunn Stamnaes, Daniel Stray, Maria Stensland, et al.
Gut|August 6, 2017
HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challengeVikas K Sarna, Gry I Skodje, Henrik M Reims, et al.
The Journal of Clinical Investigation|May 15, 2018
Disease-driving CD4+ T cell clonotypes persist for decades in celiac diseaseLouise F Risnes, Asbjørn Christophersen, Shiva Dahal-Koirala, et al.
Gastroenterology|November 6, 2017
Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten SensitivityGry I Skodje, Vikas K Sarna, Ingunn H Minelle, et al.
United European Gastroenterology Journal|March 28, 2020
Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivityJason A Tye-Din, Gry I Skodje, Vikas K Sarna, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
Science Advances|August 29, 2019
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac diseaseGautam Goel, Jason A Tye-Din, Shuo-Wang Qiao, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|June 27, 2025
Vikas K Sarna
Gastroenterology|November 18, 2017
HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten ConsumptionVikas K Sarna, Knut E A Lundin, Lars Mørkrid, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 1, 2021
In Well-Treated Celiac Patients Low-Level Mucosal Inflammation Predicts Response to 14-day Gluten ChallengeJorunn Stamnaes, Daniel Stray, Maria Stensland, et al.
Gut|August 6, 2017
HLA-DQ:gluten tetramer test in blood gives better detection of coeliac patients than biopsy after 14-day gluten challengeVikas K Sarna, Gry I Skodje, Henrik M Reims, et al.
The Journal of Clinical Investigation|May 15, 2018
Disease-driving CD4+ T cell clonotypes persist for decades in celiac diseaseLouise F Risnes, Asbjørn Christophersen, Shiva Dahal-Koirala, et al.
Gastroenterology|November 6, 2017
Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten SensitivityGry I Skodje, Vikas K Sarna, Ingunn H Minelle, et al.
United European Gastroenterology Journal|March 28, 2020
Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivityJason A Tye-Din, Gry I Skodje, Vikas K Sarna, et al.
BMJ Open|June 25, 2021
Safety and efficacy of faecal microbiota transplantation by Anaerobic Cultivated Human Intestinal Microbiome (ACHIM) in patients with systemic sclerosis: study protocol for the randomised controlled phase II ReSScue trialAnna-Maria Hoffmann-Vold, Håvard H Fretheim, Vikas K Sarna, et al.
Science Advances|August 29, 2019
Cytokine release and gastrointestinal symptoms after gluten challenge in celiac diseaseGautam Goel, Jason A Tye-Din, Shuo-Wang Qiao, et al.
The Lancet. Rheumatology|February 3, 2025
Faecal microbiota transplantation in patients with systemic sclerosis and lower gastrointestinal tract symptoms in Norway (ReSScue): a phase 2, randomised, double-blind, placebo-controlled trialHåvard Fretheim, Imon Barua, Gunnstein Bakland, et al.
Pageof 1